United Therapeutics Corporation UTHR announced that the FDA has approved the new drug application for the dry powder inhalation (DPI) formulation for its key pulmonary arterial hypertension (PAH) drug ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (UTHR), a public benefit corporation, today announced that its TETON-2 study evaluating the use of ...
Over 100,000 patients in the United States have IPF, with only two approved therapies available that only slow the course of disease progression “Completing enrollment in this trial brings us one step ...
Treprostinil 16mcg, 32mcg, 48mcg, 64mcg; per cartridge; dry pwd for inh. Ampules (2.9mL)—4; Starter Kit—1 (28 ampules with inhalation system); Refill Kit—1 (28 ampules with accessories); DPI Titration ...
Hosted on MSN
MannKind Lands A Price-Target Hike After Partner United Therapeutics Reports Strong Lung Drug Trial Results
H.C. Wainwright on Tuesday raised its price target on MannKind to $11 from $9 and reiterated its buy rating on the shares, following positive late-stage study results from partner United Therapeutics ...
CBS News pulled a "60 Minutes" report on El Salvador's CECOT prison just hours before its scheduled Sunday broadcast, saying it would air at a future time. Reuters, the news and media division of ...
United Therapeutics is making headway in unlocking a new lung disease market for its drug Tyvaso (treprostinil) with a pivotal phase 3 win in idiopathic pulmonary fibrosis (IPF). United’s Teton-2 ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the U.S. Food and Drug ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five posters across its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results